These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

51 related articles for article (PubMed ID: 20473063)

  • 1. Hematological effects of valproate in psychiatric patients: what are the risk factors?
    Vasudev K; Keown P; Gibb I; McAllister-Williams RH
    J Clin Psychopharmacol; 2010 Jun; 30(3):282-5. PubMed ID: 20473063
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Changes in red blood cells with valproate therapy.
    Ozkara C; Dreifuss FE; Apperson Hansen C
    Acta Neurol Scand; 1993 Sep; 88(3):210-2. PubMed ID: 8256557
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hematologic manifestations of long-term valproate therapy.
    May RB; Sunder TR
    Epilepsia; 1993; 34(6):1098-101. PubMed ID: 8243362
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sodium valproate, platelet dysfunction, and bleeding.
    Loiseau P
    Epilepsia; 1981 Apr; 22(2):141-6. PubMed ID: 6781890
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Successful reintroduction of valproic acid after the occurrence of pancytopenia.
    Stewart JT
    Am J Geriatr Pharmacother; 2011 Oct; 9(5):351-3. PubMed ID: 21962938
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The adverse effects of drugs on the blood.
    McVie JG
    Br J Clin Pract; 1973 Aug; 27(8):300-8. PubMed ID: 4586638
    [No Abstract]   [Full Text] [Related]  

  • 7. Valproic Acid-Induced Thrombocytopenia in Treatment-Resistant GABRB3 Genetic Epilepsy: A Case Report.
    Schuler M; Shammout A; Asif M; Mullikin A
    Cureus; 2024 Mar; 16(3):e57030. PubMed ID: 38681313
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Loxapine in the Treatment of Manic and Psychotic Symptoms in an Individual Intolerant to Multiple Mood-Stabilizing and Antipsychotic Medications.
    Im DS; Capitanov M; VandenBerg AM
    Case Rep Psychiatry; 2023; 2023():8887553. PubMed ID: 37332889
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fixed Dose Combination Tablets of Aripiprazole and Divalproex Sodium: a Pilot Pharmacokinetic Study in Human Volunteers.
    Ahmed Z; Subhan F; Ahmed S
    AAPS PharmSciTech; 2022 Aug; 23(7):232. PubMed ID: 35986197
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effects of valproic acid on skin healing: experimental study in rats.
    Biondo-Simões R; Biondo-Simões MLP; Ioshii SO; Robes RR; Dall'Antonia MO
    Acta Cir Bras; 2022; 37(4):e370403. PubMed ID: 35857935
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Incidence of Neutropenia with Valproate, Antipsychotics, and ADHD Medication Combination Treatment in Children and Adolescents.
    Oh Y; Joung YS; Choi J
    J Korean Med Sci; 2020 Jul; 35(28):e226. PubMed ID: 32686368
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dextromethorphan Protect the Valproic Acid Induced Downregulation of Neutrophils in Patients with Bipolar Disorder.
    Lu RB; Chang YH; Lee SY; Wang TY; Cheng SL; Chen PS; Yang YK; Hong JS; Chen SL
    Clin Psychopharmacol Neurosci; 2020 Feb; 18(1):145-152. PubMed ID: 31958915
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Valproic Acid and Epilepsy: From Molecular Mechanisms to Clinical Evidences.
    Romoli M; Mazzocchetti P; D'Alonzo R; Siliquini S; Rinaldi VE; Verrotti A; Calabresi P; Costa C
    Curr Neuropharmacol; 2019; 17(10):926-946. PubMed ID: 30592252
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anemia secondary to the use of sodium valproate for preventing postoperative seizures in a 79-year-old man: A case report.
    Li C; Su L; Lao M; Zhu S; Ding M
    Medicine (Baltimore); 2018 Dec; 97(50):e13626. PubMed ID: 30558048
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Significant thrombocytopenia with sodium valproate in an adult patient with alcohol dependence.
    Goyal SK; Badyal DK
    Indian J Psychiatry; 2018; 60(2):252-253. PubMed ID: 30166684
    [No Abstract]   [Full Text] [Related]  

  • 16. Megakaryocyte lineage development is controlled by modulation of protein acetylation.
    Bartels M; Govers A; Polak R; Vervoort S; van Boxtel R; Pals C; Bierings M; van Solinge W; Egberts T; Nieuwenhuis E; Mokry M; Coffer PJ
    PLoS One; 2018; 13(4):e0196400. PubMed ID: 29698469
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Risk of Thrombocytopenia During Valproic Acid Therapy: A Critical Summary of Available Clinical Data.
    Buoli M; Serati M; Botturi A; Altamura AC
    Drugs R D; 2018 Mar; 18(1):1-5. PubMed ID: 29260458
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dispensability of Annual Laboratory Follow-Up After More than 2 Years of Valproic Acid Use: A Systematic Review.
    Meijboom RW; Grootens KP
    CNS Drugs; 2017 Nov; 31(11):939-957. PubMed ID: 29214384
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Space-Time Cluster Analysis to Detect Innovative Clinical Practices: A Case Study of Aripiprazole in the Department of Veterans Affairs.
    Penfold RB; Burgess JF; Lee AF; Li M; Miller CJ; Nealon Seibert M; Semla TP; Mohr DC; Kazis LE; Bauer MS
    Health Serv Res; 2018 Feb; 53(1):214-235. PubMed ID: 28004385
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.